267 related articles for article (PubMed ID: 15179449)
1. Low-molecular-weight heparins in thrombosis and cancer: emerging links.
Mousa SA
Cardiovasc Drug Rev; 2004; 22(2):121-34. PubMed ID: 15179449
[TBL] [Abstract][Full Text] [Related]
2. Antithrombotics in thrombosis and cancer.
Mousa SA
Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):283-91. PubMed ID: 15030287
[TBL] [Abstract][Full Text] [Related]
3. Low-molecular-weight heparin in thrombosis and cancer.
Mousa SA
Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():25-30. PubMed ID: 15085463
[TBL] [Abstract][Full Text] [Related]
4. Antithrombotics in thrombosis and cancer.
Mousa SA
Hamostaseologie; 2005 Nov; 25(4):380-6. PubMed ID: 16395488
[TBL] [Abstract][Full Text] [Related]
5. Anti-thrombotics in thrombosis and cancer.
Mousa SA
Future Oncol; 2005 Jun; 1(3):395-403. PubMed ID: 16556013
[TBL] [Abstract][Full Text] [Related]
6. Heparin and low-molecular weight heparins in thrombosis and beyond.
Mousa SA
Methods Mol Biol; 2010; 663():109-32. PubMed ID: 20617415
[TBL] [Abstract][Full Text] [Related]
7. An update on heparins at the beginning of the new millennium.
Fareed J; Hoppensteadt DA; Bick RL
Semin Thromb Hemost; 2000; 26 Suppl 1():5-21. PubMed ID: 11011802
[TBL] [Abstract][Full Text] [Related]
8. Comparative effectiveness of low-molecular-weight heparins versus other anticoagulants in major orthopedic surgery: a systematic review and meta-analysis.
Sobieraj DM; Coleman CI; Tongbram V; Chen W; Colby J; Lee S; Kluger J; Makanji S; Ashaye A; White CM
Pharmacotherapy; 2012 Sep; 32(9):799-808. PubMed ID: 22744711
[TBL] [Abstract][Full Text] [Related]
9. Low-molecular-weight heparins and angiogenesis.
Norrby K
APMIS; 2006 Feb; 114(2):79-102. PubMed ID: 16519745
[TBL] [Abstract][Full Text] [Related]
10. Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival.
Nishioka J; Goodin S
J Oncol Pharm Pract; 2007 Jun; 13(2):85-97. PubMed ID: 17873108
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic therapy for the management of thrombosis: unfractionated heparin or low-molecular-weight heparin?
Spyropoulos AC
Clin Cornerstone; 2005; 7(4):39-48. PubMed ID: 16758651
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulants in thrombosis and cancer: the missing link.
Mousa SA
Expert Rev Anticancer Ther; 2002 Apr; 2(2):227-33. PubMed ID: 12113244
[TBL] [Abstract][Full Text] [Related]
13. Anticoagulants in thrombosis and cancer: the missing link.
Mousa SA
Semin Thromb Hemost; 2002 Feb; 28(1):45-52. PubMed ID: 11885025
[TBL] [Abstract][Full Text] [Related]
14. Low molecular weight heparins in the long-term treatment of venous thromboembolism.
Liapis CD; Daskalopoulos ME; Daskalopoulou SE
J Cardiovasc Surg (Torino); 2002 Aug; 43(4):495-500. PubMed ID: 12124561
[TBL] [Abstract][Full Text] [Related]
15. Partial depletion of tissue factor pathway inhibitor during subcutaneous administration of unfractionated heparin, but not with two low molecular weight heparins.
Bendz B; Hansen JB; Andersen TO; Ostergaard P; Sandset PM
Br J Haematol; 1999 Dec; 107(4):756-62. PubMed ID: 10606880
[TBL] [Abstract][Full Text] [Related]
16. Safety profile of different low-molecular weight heparins used at therapeutic dose.
Gouin-Thibault I; Pautas E; Siguret V
Drug Saf; 2005; 28(4):333-49. PubMed ID: 15783242
[TBL] [Abstract][Full Text] [Related]
17. Generic low-molecular-weight heparins: some practical considerations.
Fareed J; Leong WL; Hoppensteadt DA; Jeske WP; Walenga J; Wahi R; Bick RL
Semin Thromb Hemost; 2004 Dec; 30(6):703-13. PubMed ID: 15630677
[TBL] [Abstract][Full Text] [Related]
18. Venous thromboembolism prevention with LMWHs in medical and orthopedic surgery patients.
Deitelzweig SB; Vanscoy GJ; Niccolai CS; Rihn TL
Ann Pharmacother; 2003 Mar; 37(3):402-11. PubMed ID: 12639173
[TBL] [Abstract][Full Text] [Related]
19. The role of tissue factor pathway inhibitor in the mediation of the antithrombotic actions of heparin and low-molecular-weight heparin.
Hoppensteadt DA; Jeske W; Fareed J; Bermes EW
Blood Coagul Fibrinolysis; 1995 Jun; 6 Suppl 1():S57-64. PubMed ID: 7647223
[TBL] [Abstract][Full Text] [Related]
20. Low-molecular-weight heparins for the prevention and treatment of venous thromboembolism.
Ornstein DL; Hong-Dice YG; Papini JR
Mil Med; 2001 Jul; 166(7):593-601. PubMed ID: 11469031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
